Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 nov. 2015 16h05 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Third Quarter 2015 Results

SOLANA BEACH, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
10 nov. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke to Participate in the Brean Capital 2015 Life Sciences Summit

SOLANA BEACH, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
05 nov. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2015 Financial Results

SOLANA BEACH, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
07 oct. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Strengthens Financial Position

SOLANA BEACH, Calif., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
28 sept. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Reaches Study Enrollment Milestone Associated With Credit Facility

SOLANA BEACH, Calif., Sept. 28, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
15 sept. 2015 08h30 HE | Source: Evoke Pharma, Inc.

U.S. Food and Drug Administration's (FDA) Draft Guidance is Consistent With Evoke's Current Phase 3 Study Design and Endpoint for EVK-001

SOLANA BEACH, Calif., Sept. 15, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
18 août 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Receives Favorable Response From U.S. Food and Drug Administration Regarding Pediatric Study Plan for EVK-001

SOLANA BEACH, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
13 août 2015 16h05 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Second Quarter 2015 Results

Enrolled 130 total subjects in Phase 3 clinical trial through end of July Recent FDA draft guidance of advice on Gastroparesis mirrors Evoke's Phase 3 clinical trial protocol design SOLANA...
30 juil. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2015 Financial Results

SOLANA BEACH, Calif., July 30, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
01 juil. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma to Present at Cantor Fitzgerald Inaugural Healthcare Conference

SOLANA BEACH, Calif., July 1, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, will host an...

Page précédente